Início › Câncer (todos os tipos) › Oregon
Ensaios clínicos de Câncer (todos os tipos) em Oregon
41 estudos para Câncer (todos os tipos) estão buscando participantes em locais em Oregon.
Cidades em Oregon
Texto oficial do estudo (Inglês)
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- Providence Portland Medical Center /ID# 277727, Portland
RecrutandoFase 2
Idades 18 e acima · Mulheres · Atualizado em 1 de out. de 2026 · NCT07024784A Study of ASP3082 in Adults With Advanced Solid Tumors
- Oregon Health and Science University, Portland
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT05382559A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Oregon Health & Science University, Portland
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07192471Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Williamette Valley Cancer Institute and Research Center, Eugene
- Compass Oncology - West, Tigard
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT07566156A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Portland
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT07127874A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Investigative Site, Portland
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT06881992A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- OHSU Center for Health & Healing 1, Portland
- Oregon Health and Science University, Portland
- OSHU Center for Health and Healing 2, Portland
RecrutandoFase 2/3
Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06989437A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Willamette Valley Cancer Institute and Research Center /ID# 280617, Eugene
- Oregon Health and Science University /ID# 280071, Portland
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT07365241TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Providence Health & Services, Portland
RecrutandoFase 2
Idades 12 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT02693535Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Willamette Valley Cancer Institute, Eugene
- Providence Portland Medical Center, Portland
- Oregon Health and Science University OHSU, Portland
RecrutandoFase 2/3
Todas as idades · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT03435796Connect for Cancer Prevention Study (Connect)
- Kaiser Permanente Northwest, Portland
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 30 a 70 · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT04609072A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Oregon Health and Science University ( Site 3004), Portland
RecrutandoFase 1/2
1 Month – 17 Years · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT06941272A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- Oregon Health and Science University /ID# 272282, Portland
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT06953960A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Providence Cancer Institute, Portland
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT06253871A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- USO - Oncology Associates of Oregon, Eugene
- Asante Rogue Regional Medical Center, Medford
- Providence Portland Medical Center, Portland
- e mais 2
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06119581A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
- Asante Rogue Regional Medical Center, Medford
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT07169851A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
- Providence Portland Medical Center, Portland
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 28 de ago. de 2026 · NCT07075185IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer
- Oregon Health and Science University, Portland
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT06206941Project: Every Child for Younger Patients With Cancer
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
RecrutandoEstudo observacional
Até 25 anos · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT02402244FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Oregon Health and Science University, Portland
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05919264A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Oregon Health and Science University, Portland
RecrutandoFase 2
Idades de 1 a 39 · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT05999994Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- e mais 11
RecrutandoFase 3
Idades 18 e acima · Todos os sexos · Atualizado em 7 de ago. de 2026 · NCT06580314Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 517, Eugene
RecrutandoFase 2
Idades 18 e acima · Mulheres · Atualizado em 16 de jul. de 2026 · NCT06906341Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
- OHSU Knight Cancer Institute, Portland
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 16 de jul. de 2026 · NCT05705492A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Willamette Valley Cancer Institute and Research Center /ID# 267088, Eugene
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 13 de jul. de 2026 · NCT05650632A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Northwest Cancer Specialists /ID# 275151, Portland
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 10 de jul. de 2026 · NCT07023289First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Providence Cancer Institute Franz Clinic, Portland
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 7 de jul. de 2026 · NCT05768139Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Oregon Health and Science University, Portland
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 7 de jul. de 2026 · NCT07216443Molecular Genetics Studies of Cancer Patients and Their Relatives
- Saint Charles Health System, Bend
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Todas as idades · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT04185935A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
- GSK Investigational Site, Portland
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 25 de jun. de 2026 · NCT06431594Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- VA Portland Health Care System, Portland, OR, Portland
Recrutando
Idades de 18 a 75 · Todos os sexos · Atualizado em 17 de jun. de 2026 · NCT05486572Galleri® in the Medicare Population.
- OHSU CEDAR Clinical Trials Columbia, Astoria
- OHSU CEDAR Clinical Trials Exchange, Astoria
- OHSU CEDAR Clinical Trials Beaverton, Beaverton
- e mais 7
RecrutandoVoluntários saudáveis bem-vindos
Idades 50 e acima · Todos os sexos · Atualizado em 22 de mai. de 2026 · NCT05673018I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- Oregon Health & Science Institute (OHSU), Portland
RecrutandoFase 2
Idades 18 e acima · Todos os sexos · Atualizado em 6 de mai. de 2026 · NCT01042379CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Providence Neurological Specialties West, Portland
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 16 de abr. de 2026 · NCT03328078GEMINI-NSCLC: NSCLC Biomarker Study
- Oregon Oncology Specialists, Salem
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 5 de fev. de 2026 · NCT05236114Beat Childhood Cancer Specimen Banking and Data Registry
- Randall Children's Hospital, Portland
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Todas as idades · Todos os sexos · Atualizado em 3 de fev. de 2026 · NCT04715178Caris Biorepository Research Protocol
- Bend Memorial Clinic, Bend
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades 18 e acima · Todos os sexos · Atualizado em 21 de jan. de 2026 · NCT01499394SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Portland
RecrutandoEstudo observacional
Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774Observational Study of Iris Tumors
- Oregon Health & Science University, Portland
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2025 · NCT03809585A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
- Oregon Health & Science University, Portland
RecrutandoFase 1/2
Idades 18 e acima · Todos os sexos · Atualizado em 13 de fev. de 2025 · NCT05669430Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.